{"id":46887,"date":"2022-08-03T15:02:22","date_gmt":"2022-08-03T13:02:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/model-n-and-pfizer-innovate-drug-price-transparency-reporting\/"},"modified":"2022-08-03T15:02:22","modified_gmt":"2022-08-03T13:02:22","slug":"model-n-and-pfizer-innovate-drug-price-transparency-reporting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/model-n-and-pfizer-innovate-drug-price-transparency-reporting\/","title":{"rendered":"Model N and Pfizer Innovate Drug Price Transparency Reporting"},"content":{"rendered":"
\n

\nNEW \u2018Transparency Talks\u2019 With Pfizer and Global Pricing Innovations (GPI) Help Pharmaceutical Companies Stay Compliant With Drug Pricing<\/i>\n<\/p>\n

SAN MATEO, Calif.–(BUSINESS WIRE)–#LifeSciences<\/a>—Model N, Inc.<\/a> (NYSE: MODN), the leader in revenue optimization and compliance, today announced the launch of Transparency Talks<\/i>, a new, three-part education series for pharmaceutical companies that tackles the topic of price transparency regulations for prescription drugs. Transparency Talks<\/i> will bring together leaders from Model N, Pfizer and Global Pricing Innovations (GPI) to explore state drug pricing laws and regulations, as well as facilitate a discussion on trends, best practices and innovative approaches that help pharmaceutical companies meet regulatory compliance goals.\n<\/p>\n

<\/a><\/p>\n

\nFirst-Ever SaaS Solution for State Price Transparency Mandates<\/b>\n<\/p>\n

\nModel N has pioneered a technology-driven approach to state price transparency regulations. Its new State Price Transparency Management (SPTM) solution for the Model N Revenue Cloud is the first-ever SaaS solution built specifically to assist pharmaceutical and biotech companies in operationalizing the complete, end-to-end process for meeting State Price Transparency mandates.\n<\/p>\n

\n\u201cLife sciences companies must find an effective way to prepare and respond to fast-moving changes in state price transparency regulations, and we are excited to deliver innovative solutions to help them avoid costly mistakes,\u201d said Kyle Forcier, Senior Director of Life Sciences Product Marketing at Model N. \u201cIt\u2019s been an honor to partner with Pfizer on State Price Transparency Management, creating an innovative solution that helps navigate the fluid state drug price reporting landscape.\u201d\n<\/p>\n

\nPfizer and GPI on SPTM<\/b>\n<\/p>\n

\nThe SPTM solution was developed with the collaboration of Pfizer, the world\u2019s largest pharmaceutical company. \u201cOur collaboration with Model N has delivered a tool that helps us better manage complex state reporting requirements,\u201d said Laura Topal, Senior Director, Strategic Pricing, Pfizer. \u201cWe\u2019re proud of what we have achieved together, and we\u2019re excited about sharing our learnings with the larger pharma community.\u201d\n<\/p>\n

\nRachel Jao, Head of Commercial Strategy from GPI<\/a>, a market leader in innovative solutions for biopharma and market access, will also join Transparency Talks<\/i> to share the latest in industry best practices. \u201cMore than 20 states have drug pricing transparency laws on the books today, and there can be severe financial consequences for non-compliance,\u201d Jao said. \u201cTransparency<\/i> Talks<\/i> from Model N is a valuable way for pharma business leaders to learn more about the current regulatory environment and to explore solutions that will help them address this significant challenge.\u201d\n<\/p>\n

\nTransparency Talks<\/i> at a Glance<\/b>\n<\/p>\n

\nThe goal of Transparency Talks<\/i> is to provide pharmaceutical and biotech companies with a set of best practices and insights to manage the state price transparency process. The schedule of events is found below:\n<\/p>\n